Suppr超能文献

血清和胸腔积液N末端B型利钠肽原浓度在胸腔积液鉴别诊断中的应用

Serum and pleural fluid N-Terminal-Pro-B-Type natriuretic peptide concentrations in the differential diagnosis of pleural effusions.

作者信息

Yorgancıoğlu Arzu, Ozgen Alpaydın Aylin, Yaman Nesrin, Taneli Fatma, Bayturan Ozgür, Sakar Coşkun Ayşın, Celik Pınar

机构信息

Chest Diseases Hospital, Balikesir, Turkey.

出版信息

Tuberk Toraks. 2011;59(1):1-7.

Abstract

Currently, new biomarkers like N-Terminal-Pro-B-Type natriuretic peptide (NT-proBNP) have been used in the differential diagnosis of pleural effusions. In our study, we aimed to investigate the diagnostic value of NT-proBNP, especially in cardiac originated pleural effusions. Forty-five patients with pleural effusions were included in the study. NT-proBNP levels and biochemical markers involved in the Light's criteria were analyzed in pleural fluid and serums of the patients. Pleural fluid culture, AFB smear, cytology were performed where they were indicated according to the clinical evaluation. In patients, to whom cardiac pathology was considered to be; cardiological evaluation and echocardiography were also done. Thirty-eight pleural effusions were exudative and, 7 were transudative according to the Light's criteria. Final diagnosis were malignant effusion in 13, infection (tuberculosis/pneumonia) in 10, congestive heart failure in 21, and other conditions related with pleural effusion in 1 of the patients. Median (25th to 75th percentiles) NT-proBNP levels of serum and pleural fluid due to congestive heart failure (CHF) were 4747 pg/mL (931-15754) and 4827 pg/mL (1290-12.430) while median NT-proBNP levels of serum and pleural fluid related with non-cardiac reasons were 183 pg/mL (138-444) and 245 pg/mL (187-556) respectively. NT-proBNP levels of serum and pleural fluid were significantly high in CHF (p< 0.001 for both). When four groups were compared serum and pleural fluid NT-proBNP levels were highest in the CHF group which was followed by malignancy, infection and others (p< 0.001 for both). Fourteen of 21 patients who were accepted to have congestive heart failure as the final diagnosis by a cardiological evaluation had an exudative pleural fluid according to the Light's criteria. Serum and pleural fluid NT-proBNP levels were higher in transudates and this reached statistically significance for pleural fluid (p= 0.009). We suggest that measurement of pleural fluid NT-proBNP is a smart approach and pleural fluid NT-proBNP can reflect cardiac origin of effusions better than serum NT-proBNP and Light's criteria.

摘要

目前,诸如N末端B型利钠肽原(NT-proBNP)等新型生物标志物已被用于胸腔积液的鉴别诊断。在我们的研究中,我们旨在探讨NT-proBNP的诊断价值,尤其是在心脏源性胸腔积液中的诊断价值。45例胸腔积液患者被纳入研究。分析了患者胸腔积液和血清中NT-proBNP水平以及Light标准中涉及的生化标志物。根据临床评估,在有指征的患者中进行了胸腔积液培养、抗酸杆菌涂片、细胞学检查。对于被认为患有心脏疾病的患者,还进行了心脏评估和超声心动图检查。根据Light标准,38例胸腔积液为渗出液,7例为漏出液。最终诊断为恶性积液13例,感染(结核/肺炎)10例,充血性心力衰竭21例,1例为与胸腔积液相关的其他情况。充血性心力衰竭(CHF)患者血清和胸腔积液的NT-proBNP水平中位数(第25至75百分位数)分别为4747 pg/mL(931 - 15754)和4827 pg/mL(1290 - 12430),而非心脏原因相关的血清和胸腔积液NT-proBNP水平中位数分别为183 pg/mL(138 - 444)和245 pg/mL(187 - 556)。CHF患者血清和胸腔积液的NT-proBNP水平显著升高(两者均p < 0.001)。当比较四组时,CHF组的血清和胸腔积液NT-proBNP水平最高,其次是恶性肿瘤、感染和其他组(两者均p < 0.001)。经心脏评估最终诊断为充血性心力衰竭的21例患者中,有14例根据Light标准胸腔积液为渗出液。漏出液的血清和胸腔积液NT-proBNP水平较高,且胸腔积液达到统计学显著性(p = 0.009)。我们认为检测胸腔积液NT-proBNP是一种明智的方法,胸腔积液NT-proBNP比血清NT-proBNP和Light标准能更好地反映积液的心脏来源。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验